MedCepts

NOVEMBER 7, 2017

Doctors are natural skeptics. Remember, doctors were educated in scientific communities. Any doctor prescribing them to their patient knows that they could be placing their license at risk. In addition, it needs to be approved either by the FDA or other respective authorizing body. So is efficacy and ease of application.

Physicians 52

Physicians Medical sales reps Doctors Medical sales 52

Nixon Gwilt Law

NOVEMBER 16, 2023

With generative AI models, healthcare providers can change treatment plans on the fly, making sure they're giving the best and most up-to-date care. It may also predict health issues before they happen, letting doctors step in early—possibly even before symptoms start showing up. This uncertainty can lead to liability risks.

Healthcare 52

Healthcare Healthcare Ethics Training 52

Pharmaceutical Technology

OCTOBER 5, 2022

In 2009, former Biogen employee Michael Bawduniak filed a lawsuit claiming that Biogen had violated the False Claims Act and the Anti-Kickback Statute by providing millions of dollars to healthcare providers (HCPs) as an incentive to prescribe three of its multiple sclerosis (MS) drugs. Biogen’s activity in multiple sclerosis.

Government 59

Government Specialization Physicians Education 59

pharmaphorum

JULY 6, 2022

Some patients with COVID-19 will be able to get easier access to Pfizer’s oral antiviral therapy Paxlovid, after the FDA ruled that pharmacists would be able to prescribe the drug. Now, in addition to doctors and providers, the FDA announced pharmacists with your medical information can prescribe Paxlovid to patients.

FDA 95

FDA Doctors Side effects Patients 95

Pharma Marketing Network

JUNE 8, 2020

Don (PMN): Sure, yea patients need to be aware of their conditions and also be motivated to see their doctors for treatment right. I mean how many campaigns was I involved with, be it commercials or ads, like “Ask your doctor what’s right for you.” Mark (83Bar): So that’s the challenge.

Doctors 40

Doctors Education Physicians Marketing 40

Pharmaceutical Technology

FEBRUARY 3, 2023

The US Food and Drug Administration (FDA) has granted approval to Amgen and AstraZeneca ’s Tezspire (tezepelumab-ekko) for self-administration using a single-use, pre-filled pen for severe asthma patients aged 12 years and above. Asthma control improvement and safety profile were consistent with previous clinical trials.

Food and Drug Administration 59

Food and Drug Administration FDA Healthcare Provider Doctors 59

PM360

JUNE 11, 2022

For example, everyone must be steeped in both FDA and FTC guidelines. Typically, we think of patient partnerships in terms of their external impact—for example, to help educate doctors and payers. Once you choose a patient partner, transparency is tantamount to building a successful working relationship. Anthony Yanni. Olivier Chateau.

Patients 59

Patients Pharma Education Media 59

Medgadget

JULY 19, 2023

HFX was FDA approved in May 2015 for the treatment of chronic back and leg pain, including claims of superiority over traditional SCS treatment. These frequent in-person visits are inconvenient and time consuming for not only the patient but also for their healthcare provider.

Patients 72

Patients Healthcare Healthcare Doctors 72

Pharmaceutical Technology

FEBRUARY 1, 2023

As paediatric hospital wings are flooded with an unprecedented number of respiratory syncytial virus (RSV) cases , healthcare workers have been overwhelmed by an unusually early peak of the RSV season. This would be preferable for patients as doctors must administer Synagis to patients five times per month during peak RSV season.

Pharma 64

Pharma Pharmaceutical FDA Healthcare Provider 64

Evolve Your Success

APRIL 11, 2023

There’s less patient pain and ultimately less cost for the healthcare facility. We have launched into the US marketplace and got the product design through FDA. We had some great responses because it solves some problems on the clinician side, the patient side and the healthcare provider side. Cut out the BS.

Sales 52

Sales Medical Medical sales Media 52

Clarify Health

MAY 19, 2020

After FDA-approval comes the last critical mile of this journey: bringing the product to market. As healthcare providers (HCPs) are re-deployed to care for COVID-19 patients, many chronically-ill patients will have less frequent follow-up with their doctors.

Biopharma 52

Biopharma Physicians Marketing Prescription 52

Cadensee

JULY 20, 2021

52:21 Uri's opinion about the main problem that needs to be solved for the healthcare market with technology. It's become the main thing that the doctors are looking at now. And I think also you what you see is doctors that grew on this kind of, bedrock, are more open for this because this is now part of the culture.

Food and Drug Administration 52

Food and Drug Administration Doctors Healthcare Healthcare 52

Pharmaceutical Technology

JANUARY 6, 2023

Last year, Novartis began with a win in January, as the US Court of Appeals affirmed the validity of Gilenya’s patent, allowing the company to sue a competitor generics company for filing for FDA approval for its Gilenya generic. Gilenya is an oral medication for multiple sclerosis. Fighting Entresto generics.

Pharmaceutical 97

Pharmaceutical Doctors Healthcare Provider Prescription 97